I
Idera Pharmaceuticals Inc
F:HXXB
Idera Pharmaceuticals Inc
F:HXXB
Price:
2.8
EUR
Market Closed
Market Cap:
€174.4m
Relative Value
There is not enough data to reliably calculate the relative value of HXXB.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HXXB
Relative Value
Base Case
Not Available
Multiples Across Competitors
HXXB Competitors Multiples
Idera Pharmaceuticals Inc Competitors
Idera Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
I
|
Idera Pharmaceuticals Inc
F:HXXB
|
174.4m EUR | 42.3 | -8.8 | -10.4 | -10.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.6B USD | 6 | 87.1 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.6B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.1B USD | 6 | 20.6 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.3B USD | 9.7 | 29.4 | 22.2 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36.4B EUR | 10.3 | 33.1 | 35.8 | 36.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
